InsidersTradesSigma
Cell Impact AB (publ): directors' dealings · Finland · FIN-FSA
Explore the full management transaction log of Cell Impact AB (publ), a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Cell Impact AB (publ) has published 9 public disclosures. Market capitalisation: €76.7m. The latest transaction was reported on 2 March 2026 (Purchase). Among the most active insiders: Mats Boqvist. All data is accessible without an account.
9
Insider Decl.
0
Thresholds
€102,767
9 ops.
Buy Volume
·
0 ops.
Sell Volume
32Σ signal
Last declaration on 2 March 2026
Declarations9 total
800,000 shares@ €0.01220.013% mcap13.5% of flowBTA (betald tecknad aktie)FI:A003W625-1
Ideal exit: 23 Nov 2026 (T+270)
275,000 shares@ €0.01220.0044% mcap45.3% of flowBTA (betald tecknad aktie)FI:A003W363-1
Ideal exit: 17 Nov 2026 (T+270)
151,250 shares@ €0.01220.0024% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003W356-1
Ideal exit: 17 Nov 2026 (T+270)
2,200,000 shares@ €0.01220.035% mcap37.1% of flowBTA (betald tecknad aktie)FI:A003W355-1
Ideal exit: 17 Nov 2026 (T+270)
1,000,000 shares@ €0.01530.020% mcap100.0% of flowAktieFI:A003R854-1
Ideal exit: 24 May 2026 (T+270)
11,000,000 shares@ €0.00180.025% mcap27.0% of flowTeckningsrätt/UniträttFI:A003Q680-1
Ideal exit: 11 Apr 2026 (T+270)
9,000,000 shares@ €0.00180.021% mcap22.4% of flowTeckningsrätt/UniträttFI:A003Q556-2
Ideal exit: 6 Apr 2026 (T+270)
2,250,000 shares@ €0.00180.0053% mcap54.7% of flowBTA (betald tecknad aktie)FI:A003Q589-1
Ideal exit: 6 Apr 2026 (T+270)
3,349,008 shares@ €0.00180.0079% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003Q585-1
Ideal exit: 6 Apr 2026 (T+270)
9 of 9 declarations